Promoter holding
64.27%
OL
Olene Life Sciences Private Limited - Due diligence report
A 360° intelligence report on Olene Life Sciences Private Limited: trust score, financial health, credit view, compliance, directors, growth…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Olene Life Sciences Private Limited — 360° Intelligence Report
Generated from MCA filings & public records77/100
Trust Score
Low Risk
Olene Life Sciences Private Limited is assessed as Low Risk with a Trust Score of 77/100. Olene Life Sciences Private Limited is an active private limited indian non-government company incorporated in 2015, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Olene Life Sciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 50/100 Moderate
- Negative operating earnings - debt service depends on external support.
- Moderate gearing (D/E 38%).
Charges position: 1 open (3.00 cr) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Indian Overseas Bank | 1 | 48.0 cr |
Compliance Score: 88/100 Low Risk
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VIVEKANAND PARACHUR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SOMASHEKARA NIRVANASHETTY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
19 allotment(s) · 2 transfer(s)
Promoters hold a majority stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Operating for 10+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Outside liabilities up 2.1x in a year.
1 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence78/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment60/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 3.00 cr already registered.
- Compliance record supports lending.
Investor view65/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 1 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2024
Last AGM held
Annual general meeting
06 Aug 2024
Charge created
Indian Overseas Bank - 3.00 cr
31 Mar 2024
Latest balance sheet
Filed with ROC
23 Mar 2022
Securities allotted
5761 Equity Shares - 1.70 cr raised
31 Jan 2022
Securities allotted
3109 Equity Shares - 91.73 Lakh raised
01 Nov 2021
Securities allotted
2494 Equity Shares - 73.58 Lakh raised
23 Oct 2021
Securities allotted
1477 Equity Shares - 43.58 Lakh raised
07 Oct 2021
Securities allotted
1017 Equity Shares - 30.01 Lakh raised
31 Mar 2020
Share transfer (FY 2020)
3750.00000000 shares to Vivekanand Parachur
Share transfer (FY 2020)
3750.00000000 shares to Somashekara Nirvanashetty
30 Sep 2019
Director ceased
POOJA SRISRIMAL
01 Aug 2019
Securities allotted
2334 Equity Shares - 61.78 Lakh raised
04 Jul 2019
Securities allotted
12 Equity Shares - 31,764.00 raised
03 Jun 2019
Securities allotted
1322 Equity Shares - 34.99 Lakh raised
24 May 2019
Securities allotted
56670 Equity Shares - 56,670.00 raised
10
Key Observations
Auto-generated from the data aboveRevenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a majority stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 19 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Sbfhealthcare | U85110KA2006PTC038729 | Bangalore North, Karnataka, India |
| Bonaiyu Health Private Limited | U24100KA2015PTC083985 | Bangalore, Karnataka, India |
| Tamdar Marine Private Limited | U29309TN2021PTC148552 | Chennai, Tamil Nadu, India |
| Cisgen | U73100TN2017PTC115332 | Chennai, Tamil Nadu, India |
| Cyran Ai Solutions | U74999DL2018PTC329095 | New Delhi, Delhi, India |
| Charcoal Technologies Private Limited | U74999KA2017PTC101782 | Bangalore, Karnataka, India |
| Ge Renewable R&D India Private Limited | U72100DL1993PTC053789 | New Delhi, Delhi, India |
| Oncodiscover | U73100MH2013PTC246961 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Olene Life Sciences Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Olene Life Sciences Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Olene Life Sciences Private Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Olene Life Sciences Private Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Olene Life Sciences Private Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Olene Life Sciences Private Limited an active company?
Olene Life Sciences Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Olene Life Sciences Private Limited financially healthy?
Olene Life Sciences Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.
Should I do business with Olene Life Sciences Private Limited?
Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Olene Life Sciences Private Limited?
Promoters hold a majority stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Olene Life Sciences Private Limited have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Olene Life Sciences Private Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Olene Life Sciences Private Limited?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
